lisocabtagene maraleucel,,Cyclophosphamide,Fludarabine
BMS
['lisocabtagene', 'mantle,(-dismantle)', 'breyanzi', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'lymphoma', 'follicular', 'bristol']
bristol myers squibb s breyanzi (lisocabtagene maraleucel) delivers deep and durable responses in relapsed or refractory follicular lymphoma and mantle cell lymphoma in transcend clinical trials presented at icml 2023 #businesswire 
Stock Market News and Press Releases. #StockMarket & #Crypto